Clinical Medicine Done with Clinical Accuracy

Year : 2026 | Volume : 03 | Issue : 01 | Page : 6 19
    By

    V Basil Hans,

  1. Professor, Srinivas University, Mangalore, India

Abstract

The advancement of clinical medicine has progressively underscored the significance of accuracy in diagnosis and therapy. This article examines the concept of “Clinical Medicine Administered with Clinical Precision,” emphasising how innovations in diagnostics, data analytics, and personalised treatments are transforming the healthcare environment. Clinicians can provide therapy that is not only successful but also personalised to each patient’s requirements by combining evidence-based practices with patient-specific factors including genetic profiles, comorbidities, and real-time biometrics. The practice of clinical medicine is changing in a big way because medical knowledge is growing faster than ever before. There is a rising focus on precision in healthcare, which means that diagnosis, treatment, and patient management are all tailored to the individual. This is changing traditional models of care that were focused on broad protocols and population-based methods. Clinical precision encompasses both the accuracy of diagnostic instruments and therapeutic interventions, as well as the intentional and systematic application of clinical judgement considering each patient’s biological, environmental, and lifestyle aspects. Several important advances have come together to make this method possible: high-resolution diagnostic imaging, molecular and genetic testing, digital health records, and artificial intelligence. These new technologies let doctors shift away from a “one-size- fits-all” strategy and towards a more detailed, data-driven, and patient-centered way of providing care. The essay talks about how new technologies like AI, clinical decision support systems, and molecular diagnostics might help make this precision-driven strategy possible. Case studies demonstrate that clinical precision promotes patient outcomes, diminishes medical errors, and optimises resource utilisation. This move towards precision in clinical practice is a big step towards medicine that is more responsive, predictive, and focused on the patient.

Keywords: Personalised Medicine, Clinical Precision, Evidence-Based Practice, Diagnostic Accuracy, Patient-Centered Care, Medical Technology, Precision Healthcare

[This article belongs to Emerging Trends in Personalized Medicines ]

How to cite this article:
V Basil Hans. Clinical Medicine Done with Clinical Accuracy. Emerging Trends in Personalized Medicines. 2026; 03(01):6-19.
How to cite this URL:
V Basil Hans. Clinical Medicine Done with Clinical Accuracy. Emerging Trends in Personalized Medicines. 2026; 03(01):6-19. Available from: https://journals.stmjournals.com/etpm/article=2026/view=236740


References

  1. Lin JZ, Long JY, Wang AQ, Zheng Y, et al. Precision medicine: In need of guidance and surveillance. J Med Ethics. 2017;43(2):134–140. doi: 1136/medethics-2016-103747.
  2. Akhoon N. Precision medicine: A new paradigm in therapeutics. J Pharm Bioallied Sci. 2021;13(2):169–176. doi: 4103/jpbs.jpbs_692_20.
  3. Morens DM. Thoughts on the relevance of medical history. Hawaii Med J. 1995 Nov;54(11):768–9. PMID: 8586545.
  4. Datta A. Clinical skill: The ebbing art of medicine. J Family Med Prim Care. 2021;10(6):2101–2104. doi: 10.4103/jfmpc.jfmpc_2386_20.
  5. Rongen GAR, Marquet P, van Gerven JMA; EACPT research working group. The scientific basis of rational prescribing. A guide to precision clinical pharmacology based on the WHO 6-step method. Eur J Clin Pharmacol. 2021 May;77(5):677–683. doi:10.1007/s00228-020-03044-2. PMID: 33210160. PMCID: PMC7673685.
  6. Polasek TM, Shakib S, Rostami-Hodjegan A. Precision medicine technology reality not hype: the example of model-informed precision dosing. F1000Research. 2019 Dec 17;8:1709. doi:10.12688/f1000research.20489.2.
  7. Nassar SF, Raddassi K, Ubhi B, Doktorski J, et al. Precision medicine: Steps along the road to combat human cancer. Mol Cancer Res. 2020;18(7):933–944. doi: 1158/1541-7786.MCR-19-1075.
  8. Delaney SK, Hultner ML, Jacob HJ, Ledbetter DH, et al. Towards clinical genomics in everyday medicine: Perspectives and recommendations. Expert Rev Mol Diagn. 2016;16(5):521–532. doi: 1586/14737159.2016.1165112.
  9. Halim-Fikri H, Rahayu-Karmilla Syed-Hassan SN, Wan-Juhari WK, Ghani SNA, et al. Central resources of variant discovery and annotation and their role in precision medicine. Brief Bioinform. 2023;24(2):bbad045. doi: 1093/bib/bbad045.
  10. Horton RH, Lucassen AM. Recent developments in genetic and genomic medicine. Clin Med (Lond). 2019;19(1):63–67. doi: 7861/clinmedicine.19-1-63.
  11. Wiita AP, Schrijver I. Clinical application of high-throughput molecular screening techniques for pharmacogenomics. Pharmacogenomics. 2011;12(6):841–854. doi: 2217/pgs.11.31.
  12. Swanson BN. Delivery of high-quality biomarker assays. Pharmacogenomics J. 2002;2(4):237–239. doi: 1038/sj.tpj.6500116.
  13. Capobianco E. Data-driven clinical decision processes: It’s time. J Transl Med. 2019;17(1):332. doi: 1186/s12967-019-2088-6.
  14. Yang S, Wei R, Guo JZ, Xu LD. Semantic inference on clinical documents: Merging machine learning algorithms with an inference engine for efficient clinical diagnosis and therapy. IEEE Access. 2017;5:3529–3546. doi: 1109/ACCESS.2017.2672975.
  15. Muluye K, Adane D, Abebe M. Processing medical data: A systematic review. J Med Syst. 2013;37(6):9990. doi: 1007/s10916-013-9990-6.
  16. James BC, Edwards DP, James AF, Bradshaw RL, et al. An efficient, clinically natural electronic medical record system that produces computable data. J Am Med Inform Assoc. 2017;24(1):35–44. doi: 1093/jamia/ocw099.
  17. Capobianco E. Systems and precision medicine approaches to diabetes heterogeneity: A big data perspective. Clin Pharmacol Ther. 2017;101(2):209–218. doi: 1002/cpt.533.
  18. Car J, Sheikh A, Wicks P, Williams MS. Beyond the hype of big data and artificial intelligence: Building foundations for knowledge and wisdom. BMC Med. 2019;17(1):143. doi: 1186/s12916-019-1372-7.
  19. Dash S, Shakyawar SK, Sharma M, Kaushik S. Big data in healthcare: Administration, analysis, and future prospects. J Big Data. 2019;6:54. doi: 1186/s40537-019-0217-0.
  20. Isetts B, Olson A, Schommer J. Reframing the medication experience in pharmacy using seminal concepts of patient-centered care: Implications for practice. Res Social Adm Pharm. 2021;17(1):152–160. doi: 1016/j.sapharm.2020.02.012.
  21. Guirguis M, Thompson E, Miller J, Sommer R, et al. Qualitative examination of shared decision-making in Canada’s largest health system: More work to be done. Health Expect. 2021;24(4):1235–1245. doi: 1111/hex.13245.
  22. Ervin KE, Blackberry I, Haines H. Putting shared decision-making into action in Australia. Asia Pac J Health Manag. 2016;11(2):10–11. doi: 24083/apjhm.v11i2.177.
  23. Matlock DD, Ito Fukunaga M, Tan A, Knoepke C, et al. Enhancing the efficacy of Medicare’s shared decision-making mandates through implementation science: Illustrations using the PRISM framework. Implement Sci Commun. 2020;1:83. doi: 1186/s43058-020-00071-3.
  24. Yankeelov TE, Hormuth DA, Lima EABF, Lorenzo G, et al. Designing clinical trials for patients who are not average. Nat Rev Clin Oncol. 2023;20(2):77–92. doi: 1038/s41571-022-00690-4.
  25. Laber EB, Tsiatis A, Davidian M. Interpretable dynamic treatment regimes. J Am Stat Assoc. 2016;111(514):370–385. doi: 1080/01621459.2015.1131837.
  26. Gupta S, Smith TR, Broekman MLD. Ethical considerations of neuro-oncology trial design in the era of precision medicine. Neurooncol Pract. 2017;4(4):231–238. doi: 1093/nop/npw031.
  27. Kadam RA. Informed consent process: An advancement toward enhancing its significance. Perspect Clin Res. 2017;8(3):107–110. doi: 4103/picr.PICR_147_16.
  28. Chen D. Ethical frameworks of informed consent in the era of paediatric precision medicine. BMC Med Ethics. 2024;25(1):18. doi: 1186/s12910-024-00945-6.
  29. List JM, Palevsky P, Tamang S, Crowley S, et al. Eliminating algorithmic racial bias in clinical decision support algorithms: Use cases from the Veterans Health Administration. J Am Med Inform Assoc. 2023;30(5):857–866. doi: 1093/jamia/ocad021.
  30. Szymczak JE, Fiks AG, Craig S, Mendez DD, et al. Access to what for whom? How care delivery innovations impact health equity. Milbank Q. 2023;101(2):436–468. doi: 1111/1468-0009.12606.
  31. Bilkey GA, Burns BL, Coles EP, Mahede T, Baynam G, Nowak KJ. Enhancing precision medicine for public health. Front Public Health. 2019;7:42. doi: 3389/fpubh.2019.00042.
  32. Ronquillo JG, Weng C, Lester WT. Evaluating the preparedness of precision medicine interoperability: An exploratory analysis of the National Institutes of Health genetic testing registry. J Health Inform Innov. 2017;24(4):918–926. doi: 14236/jhi.v24i4.918.
  33. Grey M, Meehan J, Turnbull AK, Martínez-Pérez C, et al. The significance of the tumour microenvironment and hypoxia in implementing a precision medicine strategy in veterinary oncology. Vet Comp Oncol. 2020;18(4):567–580. doi: 1111/vco.12572.
  34. Daron-Mathis SE. Cancer stem cells in the screening of anticancer drugs for central nervous system tumours [dissertation]. Huntington (WV): Marshall University; 2015. Available from: https://mds.marshall.edu/etd/906
  35. Karattuthodi MS, Thorakkattil SA, Kuzhiyil AK, Chandrasekhar D, et al. Implementation of virtual clinical pharmacy services by incorporating medical professionals and pharmacy students: A novel patient-oriented system to advance healthcare in India. J Pharm Policy Pract. 2022;15(1):74. doi: 1186/s40545-022-00456-1.
  36. Almidani E, Khadawardi E, Alshareef T, Saadeh S, et al. Departmental collaborative approach for enhancing inpatient clinical documentation: A five-year experience. BMJ Open Qual. 2018;7(4):e000318. doi: 1136/bmjoq-2018-000318.
  37. Meguid C, Ryan CE, Edil BH, Schulick RD, et al. Establishing a framework for building multidisciplinary programs. J Multidiscip Healthc. 2015;8:115–121. doi: 2147/JMDH.S76895.
  38. Key KD, Lewis EY. Sustainable community engagement in a continuously evolving health system. J Health Care Poor Underserved. 2018;29(3):1101–1114. doi: 1353/hpu.2018.0081.
  39. Johnson M, Goldberg C, Willies-Jacobo L, Wan L, et al. Implementation and outcomes of a community assessment service-learning activity within academic learning communities. Acad Med. 2019;94(9):1360–1367. doi: 1097/ACM.0000000000002765.
  40. Nicodemus BC. Designing an instructor’s manual for introducing cultural concepts in the medical school curriculum. J Med Educ. 1989;64(6):456–462.
Regular Issue Subscription Review Article
Volume 03
Issue 01
Received 11/10/2025
Accepted 24/10/2025
Published 25/01/2026
Publication Time 106 Days
105

Login


My IP

PlumX Metrics